Result of AGM

2 January 2024

Apollon Formularies Plc

Result of AGM

Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company") is pleased to announce that following the Company's Annual General Meeting held on 29 December 2023, all resolutions were duly passed.

-ENDS-

For additional information, please visit www.apollon.org.uk or contact:

Apollon Formularies                                                     

Tel:                                                      [phone]

Stene Jacobs                                      [e-mail]

Peterhouse Capital Limited (Corporate Adviser)             

Tel:                                                       [phone]

Guy Miller                                           [e-mail]

About Apollon Formularies and Apollon Formularies Jamaica

Apollon Formularies plc is an international medical cannabis and medicinal mushroom pharmaceutical company headquartered in the United Kingdom. Apollon Formularies Jamaica Limited is a pharmaceutical company incorporated and operating in the Commonwealth of Jamaica since 2016. Apollon Jamaica is licensed by the Jamaican government's Cannabis Licensing Authority (CLA) to cultivate (R&D), perform research and development, process, and sell medical cannabis therapeutic products that include legal medical cannabis to treat various illnesses under medical supervision.

---

---